Search results for " Pandemic"
Article
A Look at the Affinity Chromatography Landscape
In a pandemic situation, he notes that production of 40 million doses of flu vaccine is possible in one day with 54 L of membrane.
Nanofibers for affinity chromatography
A number of different …
Article
Modern Manufacturing Key to More Effective Vaccines
Hopefully, the research community will devise a more reliable and effective universal flu vaccine before the next, much-feared influenza pandemic strikes.
References
1. A. Powaleny, “New Repo…
Article
Microbiological Testing: Time is of the Essence
Vaccines drive test development
The need for a rapid response to a possible influenza pandemic in the first decade of the 2000s spurred the development of RMMs, according to McKee. Alternative stra…
Article
Vaccine Development Faces Urgency and Challenges
The urgent need for new treatments to combat Zika and related birth defects also illustrates the inadequacies in the current world health infrastructure to combat epidemic and pandemic diseases. Exper…
Poster
Biacore™ systems in vaccine development and production
The growing public awareness of a potential pandemic requiring rapid treatment of millions of healthy individuals has spurred renewed interest in vaccines. Vaccination campaigns mean that often very…
Article
Fluid Handling in Biopharma Facilities
For example, flexibility is key in the case of manufacturing facilities that have to deal with multi-products for seasonal vaccines or pandemic response vaccines.
Hutchinson (Parker domnick hunter…
Article
Modular Manufacturing Platforms for Biologics
Therapeutic treatments produced via a modular vaccine suite—a pandemic-ready modular facility—could be a good option in the future when dealing with the proliferation of tropical diseases and regional…
Article
Q&As with Industry Leaders
…tions R&D, Cytiva
Lessons Learned from the Biopharma Industry's Response to the COVID-19 Pandemic
James Blackwell, President, Windshire Group, LLC
Common Challenges in Cross-Fun…
Article
FDA Seeks Metrics to Define Drug Quality
…ant facilities, minimum raw material stocks, and contingency plans for Act-of-God situations such as pandemics. Firms generally consider metrics for contractors similar to those applied internally, b…
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
If facing a pandemic, the world would need more than 13 billion doses to protect a naïve population with two immunizations. To put that in perspective, in 2011, 25 of the world’s leading vaccine manuf…